Announcements Trials
Browse Landscape

Status

Available 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 204Observational 31Expanded_access 2

Sponsor

Cancer Type

Breast 18Gastrointestinal 5Thoracic 4Genitourinary 4Gynecologic 3Sarcoma 2Head & Neck 2CNS 2Lymphoid 1Endocrine 1Dermatologic 1

Conditions

Sarcoma 13Gastrointestinal Stromal Tumors 7Ovarian Neoplasms 5Neoplasms 5Osteosarcoma 4Sarcoma, Ewing 3Prostatic Neoplasms 3Pancreatic Neoplasms 3Lymphoma 3Uterine Neoplasms 2Stomach Neoplasms 2Sarcoma, Synovial 2Rhabdoid Tumor 2Neuroectodermal Tumors, Primitive 2Multiple Myeloma 2Lymphoma, Non-Hodgkin 2Lymphoma, Large B-Cell, Diffuse 2Leukemia 2Hodgkin Disease 2Endometrial Neoplasms 2Desmoid Tumors 2Chondrosarcoma 2Carcinoma, Squamous Cell 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Wilms Tumor 1Waldenstrom Macroglobulinemia 1Uterine Cervical Neoplasms 1Rhabdomyosarcoma 1Retinoblastoma 1

Interventions

Proton Pump Inhibitors 1Hydrocortisone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Expanded_access × Breast Neoplasms × Sarcoma × Clear all
NCT04091295 2026-03-04

BLESSED: Expanded Access for DNG64-CAR-V for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of Breast

Aveni Foundation

Available
BreastGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Chondrosarcoma, Chordoma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Osteosarcoma, Neurofibrosarcoma

NCT05974410 2025-10-02

Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients

AVM Biotechnology Inc

Available
BreastCNSGastrointestinalGenitourinaryGynecologicLymphoidSarcoma

Brain Neoplasms, Breast Neoplasms, Carcinoma, Squamous Cell, Glioblastoma, Hodgkin Disease, Lymphoma, Non-Hodgkin, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡